KISQALI vs NEXAVAR

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. KISQALI and NEXAVAR are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	KISQALI	NEXAVAR
Rating	70/100	New
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RIBOCICLIB SUCCINATE	SORAFENIB TOSYLATE
Manufacturer	Novartis	Bayer Hlthcare
Dosage forms	Tablet	Tablet
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	None
Treats	Breast Neoplasms	Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

kisqali nexavar

Rating

70/100

New

Pharmacy pays

—

Type

Active ingredient

RIBOCICLIB SUCCINATE

SORAFENIB TOSYLATE

Manufacturer

Novartis

Bayer Hlthcare

Dosage forms

Tablet

Drug class

Kinase Inhibitor

Boxed warning

None

Treats

Breast Neoplasms

Renal Cell Carcinoma, Hepatocellular Carcinoma, Thyroid Neoplasms

Frequently asked questions

What is the difference between Kisqali and Nexavar?

Kisqali contains Ribociclib Succinate, while Nexavar contains Sorafenib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.